Fundz

Fundz Deep Dive

Everything you need to win Elif Aral — in one platform.

Who to reach, what to say, and why now on Elif Aral — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Elif Aral — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Pfizer Appoints Elif Aral As Regional President for Middle East, Russia, and Africa (Mera)

PUBLIC · PFESep 05, 2024•almost 2 years ago

Position

President

Company

Pfizer

Elif Aral
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticals

Description

Pfizer has announced the appointment of Elif Aral as the Regional President for Middle East, Russia, and Africa (MERA), effective September 2024. In her new role, Elif will spearhead operations in the region and drive strategic initiatives to improve healthcare access and equity, working closely with regional partners and governments to ensure Pfizer's leading portfolio and breakthroughs reach those in need.

Company Information

Company

Pfizer

Location

66 Hudson Blvd E

New York, New York, United States

About

Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. Seagen is recognized for its advancements in cancer care and plays a significant role in the oncology market. Its dedication to research and development underpins its success in the competitive biotech landscape.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Pfizer's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.